These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anidulafungin: a new echinocandin with a novel profile. Vazquez JA Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974 [TBL] [Abstract][Full Text] [Related]
5. [Potential of anidulafungin in hematological patients]. Vázquez López L; Ruiz Camps I Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():44-50. PubMed ID: 19572434 [TBL] [Abstract][Full Text] [Related]
6. Anidulafungin in the treatment of patients with invasive candidiasis. Kett DH; Cubillos GF Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S99-S102. PubMed ID: 19013348 [TBL] [Abstract][Full Text] [Related]
7. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections. Cross SA; Scott LJ Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections. Kuti EL; Kuti JL Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1287-300. PubMed ID: 20822479 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficacy of anidulafungin for the treatment of oesophageal candidiasis, candidemia and invasive candidiasis]. Montejo González JC; Catalán González M; León Gil C Rev Iberoam Micol; 2008 Jun; 25(2):107-18. PubMed ID: 18473505 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology and antifungal properties of anidulafungin, a new echinocandin. Estes KE; Penzak SR; Calis KA; Walsh TJ Pharmacotherapy; 2009 Jan; 29(1):17-30. PubMed ID: 19113794 [TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Moen MD; Lyseng-Williamson KA; Scott LJ Drugs; 2009; 69(3):361-92. PubMed ID: 19275278 [TBL] [Abstract][Full Text] [Related]
12. Anidulafungin--state of affairs from a clinical perspective. Vehreschild JJ; Kümmerle T; Karthaus M; Cornely OA Mycoses; 2007; 50 Suppl 1():38-43. PubMed ID: 17394608 [TBL] [Abstract][Full Text] [Related]
13. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
15. Anidulafungin for the treatment of invasive candidiasis. Mayr A; Aigner M; Lass-Flörl C Clin Microbiol Infect; 2011 Mar; 17 Suppl 1():1-12. PubMed ID: 21251147 [TBL] [Abstract][Full Text] [Related]
16. Anidulafungin: a new echinocandin for the treatment of fungal infections. Cohen-Wolkowiez M; Benjamin DK; Steinbach WJ; Smith PB Drugs Today (Barc); 2006 Aug; 42(8):533-44. PubMed ID: 16969430 [TBL] [Abstract][Full Text] [Related]
17. Early clinical experience with anidulafungin at a large tertiary care medical center. Brielmaier BD; Casabar E; Kurtzeborn CM; McKinnon PS; Ritchie DJ Pharmacotherapy; 2008 Jan; 28(1):64-73. PubMed ID: 18154476 [TBL] [Abstract][Full Text] [Related]